NSEESOP/ESOS/ESPS1d ago · 17 Nov 2026, 05:32 pm
ESOP/ESOS/ESPS
Nephrocare Health Services Limited · NEPHROPLUS
✦ AI Summaryesop_esos_esps
Nephrocare Health Services Limited has informed the Exchange regarding the allotment of 342130 equity shares pursuant to the exercise of stock options under NephroPlus Employees Stock Option Scheme, 2011.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nephrocare Health Services Limited has informed the Exchange regarding of 342130 Options.
Attachments (1)
📄pdf
Download →
NEPHROCARE1_17112026173230_20261117_Reg_30_ESOP_Exercise_Allotment_clean_signed.pdf
View document text
November 17, 2026 Ref: NEPHROPLUS/SE/102
To To
BSE Limited National Stock Exchange of India Limited
P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E),
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 544647 Scrip Symbol: NEPHROPLUS
Through: BSE Listing Centre Through: NEAPS
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Allotment of Equity Shares pursuant to Exercise of Stock
Options under NephroPlus Employees Stock Option Scheme, 2011.
Dear Sir / Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III and other applicable
provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI Listing Regulations”), we hereby inform you that the Nomination and Remuneration
Committee (“NRC”) of the Board of Directors of Nephrocare Health Services Limited (“the
Company”), by way of a circular resolution passed on November 17, 2026, has approved the
allotment of 3,42,130 (Three Lakh Forty-Two Thousand One Hundred Thirty only) equity
shares of face value of ₹2/- each, fully paid-up, pursuant to the exercise of stock options by
eligible employees under the NephroPlus Employees Stock Option Scheme, 2011 (“ESOP
2011”). These equity shares shall rank pari passu with the existing equity shares of the
Company in all respects.
Consequent to the aforesaid allotment, the issued, subscribed and paid-up equity share
capital of the Company has increased from ₹20,11,18,028, comprising 10,05,59,014 equity
shares of face value of ₹2/- each, to ₹20,18,02,288, comprising 10,09,01,144 equity shares of
face value of ₹2/- each.
The Company has obtained the in-principle approvals for listing of the aforesaid equity shares
from the National Stock Exchange of India Limited vide letter no. NSE/LIST/54518 dated May
11, 2026, and from BSE Limited vide letter no. DCS/ESOP/IP/RD/062/2026-27 dated May 11,
2026.
The disclosures required under Regulation 10(c) of the SEBI (Share Based Employee Benefits
and Sweat Equity) Regulations, 2021, are enclosed as Annexure I.
Further, the details required under Regulation 30 of the SEBI Listing Regulations read with
SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30,
2026, are enclosed as Annexure II.
The aforesaid information is also being made available on the Company's website at
www.nephroplus.com
Yours faithfully,
For Nephrocare Health Services Limited
(Formerly Nephrocare Health Services Private Limited)
Kishore Kathri
Company Secretary and Head Legal
Membership No.: F9895
Encl: a/a
Annexure I
Sr. Particulars Remark
1 Company name and address of Nephrocare Health Services Limited
Registered Office (Formerly Nephrocare Health Services Private
Limited)
5th Floor, D Block, iLabs Centre, Plot 18, Software
Units Layout, Survey No. 64, Shaikpet, Hyderabad,
500081
2 Name of the recognized Stock BSE Limited (BSE)
Exchanges on which the company’s National Stock Exchange of India Limited (NSE)
shares are listed
3 Filing date of the statement April 10, 2026
referred in regulation 10(b) of the
SEBI (Share Based Employee
Benefits and Sweat Equity)
Regulations, 2021 with the
recognized Stock Exchange
4 Filing Number, if any Reference of In-principle Approval
a. NSE - NSE/LIST/54518 dated May 11, 2026
b. BSE - DCS/ESOP/IP/RD/062/2026-27 dated
May 11, 2026
5 Title of the Scheme pursuant to NephroPlus Employees Stock Option Scheme,
which shares are issued, if any 2011 ("ESOP 2011")
6 Kind of security to be listed Equity Shares
7 Par value of the shares ₹ 2/- each
8 Date of issue of shares November 17, 2026
9 Number of shares issued 3,42,130 fully paid-up equity shares of ₹2/- each
10 Share Certificate No., if applicable Not Applicable
11 Distinctive number of the share, if 10,05,59,015 to 10,09,01,144 (both inclusive)
applicable
12 ISIN Number of the shares if issued INE428V01029
in Demat
13 Exercise price per share Refer Annexure A
14 Premium per share Refer Annexure A
15 Total Issued shares after this issue 10,09,01,144
16 Total Issued share capital after this ₹ 20,18,02,288
issue
17 Details of any lock-in on the shares Not Applicable
18 Date of expiry of lock-in Not Applicable
Whether shares identical in all The equity shares allotted shall rank pari passu
19 respects to existing shares if not, and are identical in all respects with the existing
when will they become identical? equity shares including payment of dividend and
other rights.
20 Details of listing fees, if payable Not Applicable
Annexure II
Sr. Particulars Details
1. Brief details of options The present instance pertains to the allotment of
granted 3,42,130 equity shares of ₹2/- each, pursuant to the
exercise of options under the NephroPlus Employees
Stock Option Scheme, 2011 ("ESOP 2011").
2. Whether the scheme is in Yes
terms of SEBI (Share Based
Employee Benefits and
Sweat Equity) Regulations,
2021.
3. Total number of shares The present instance pertains to the allotment of
covered by these options 3,42,130 equity shares of ₹2/- each, pursuant to the
exercise of options under ESOP 2011.
4. Pricing formula The Exercise Price payable by an Employee upon
exercise of the Options shall be as specified in the
respective Grant Letter(s) issued under the ESOP 2011
and shall be payable in accordance with the terms and
conditions thereof. For details, please refer to
Annexure A.
5. Options vested The Options exercised in the present instance had
vested in accordance with the terms of ESOP 2011
6. Time within which option and the respective Grant Letter(s).
may be exercised
7. Options exercised Options (as adjusted for the sub-division and bonus
issue referred to in Item 9 below) entitling the holders
to 3,42,130 equity shares of face value ₹2/- each were
exercised for the current allotment.
8. Money realized by exercise ₹5,55,13,127.86 (Rupees Five Crore Fifty-Five Lakh
of options Thirteen Thousand One Hundred Twenty-Seven and
Eighty-Six Paise only) excluding applicable taxes
9. Total number of shares Each stock option granted under the ESOP 2011
arising as a result of originally entitled the option holder, upon exercise, to
exercise of options subscribe to one (1) equity share of the Company
having a face value of ₹10/- each.
Subsequently, pursuant to the sub-division of every
equity share of face value ₹10/- each into five (5)
equity shares of face value ₹2/- each, approved by the
shareholders of the Company on May 26, 2025, and
the subsequent bonus issue in the ratio of 2:1 (i.e.,
two bonus equity shares for every one equity share
held), approved by the Board of Directors and the
shareholders on the same date, the outstanding stock
options were appropriately adjusted in accordance
with the provisions of the ESOP 2011 and Regulation
5 of the SEBI (Share Based Employee Benefits and
Sweat Equity) Regulations, 2021 ("SEBI SBEB
Regulations"), so as to preserve the value of the
options and ensure that the employees were neither
advantaged nor disadvantaged on account of such
corporate actions.
Consequently, each original stock option became
exercisable into fifteen (15) equity shares of face
value ₹2/- each, with the exercise price being
correspondingly adjusted in accordance with the
adjustment formula prescribed under the ESOP 2011
and the applicable provisions of the SEBI SBEB
Regulations.
Accordingly, 3,42,130 equity shares of face value ₹2/-
each have arisen and been allotted pursuant to the
valid exercise of the corresponding adjusted stock
options under the ESOP 2011.
10. Options lapsed Not Applicable.
11. Variation of terms of Not Applicable.
options
12. Brief details of significant Options are granted, vested and exercised in
terms accordance with the provisions of ESOP 2011 and the
SEBI (Share Based Employee Benefits and Sweat
Equity) Regulations, 2021. The ESOP 2011 is
administered by the Nomination and Remuneration
Committee of the Board of Directors of the Company.
The Options granted under the ESOP 2011 vest over
such per
[Showing first 8,000 characters — download PDF for full document]